Relationship between the development of hyperlipidemia in hypothyroidism patients
- PMID: 36097119
- DOI: 10.1007/s11033-022-07423-z
Relationship between the development of hyperlipidemia in hypothyroidism patients
Retraction in
- 
  
  Retraction Note: Relationship between the development of hyperlipidemia in hypothyroidism patients.Mol Biol Rep. 2023 Apr;50(4):3969. doi: 10.1007/s11033-023-08312-9. Mol Biol Rep. 2023. PMID: 36750539 No abstract available.
Abstract
As shown in the previous studies, hypothyroidism (HT) is identified to be closely associated with the elevated plasma levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), and with the decreased plasma levels of high density lipoprotein cholesterol (HDL-C). On the other hand, the thyroid hormone (TH), which has been considered as a vital hormone produced and released by the thyroid gland, are well-established to regulate the metabolism of plasma TC; whereas other evidence proposed that the thyroid-stimulating hormone (TSH) also regulated the plasma cholesterol metabolism independently of the TH, which further promotes the progression of hyperlipidemia. Nevertheless, the potential mechanism is still not illustrated. It is worth noting that several studies has found that the progression of HT-induced hyperlipidemia might be associated with the down-regulated plasma levels of TH and the up-regulated plasma levels of TSH, revealing that HT could promote hyperlipidemia and its related cardio-metabolic disorders. Otherwise, multiple novel identified plasma proteins, such as proprotein convertase subtilisin/kexin type 9 (PCSK9), angiopoietin-like protein (ANGPTLs), and fibroblast growth factors (FGFs), have also been demonstrated to embrace a vital function in modulating the progression of hyperlipidemia induced by HT. In the present comprehensive review, the recent findings which elucidated the association of HT and the progression of hyperlipidemia were summarized. Furthermore, other results which illustrated the underlying mechanisms by which HT facilitates the progression of hyperlipidemia and its cardio-metabolic disorders are also listed in the current review.
Keywords: HDL-C; Hypothyroidism; LDL-C; Total cholesterol; Triglyceride.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
References
- 
    - Lauffer P, Zwaveling-Soonawala N, Naafs JC, Boelen A, van Trotsenburg ASP (2021) Diagnosis and Management of Central Congenital Hypothyroidism. Front Endocrinol (Lausanne) 12:686317 - DOI
 
- 
    - Ejaz M, Kumar P, Thakur M, Bachani P, Naz S, Lal K, Shahid W, Shahid S, Jahangir M, Rizwan A (2021) Comparison of Lipid Profile in Patients With and Without Subclinical Hypothyroidism. Cureus 13(8):e17301
 
- 
    - Willard DL, Leung AM, Pearce EN (2014) Thyroid function testing in patients with newly diagnosed hyperlipidemia. JAMA Intern Med 174(2):287–289 - DOI
 
- 
    - Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, Abdulazeem H, Aertgeerts B, Beecher D, Brito JP, Farhoumand PD, Singh Ospina N, Rodondi N, van Driel M, Wallace E, Snel M, Okwen PM, Siemieniuk R, Vandvik PO, Kuijpers T, Vermandere M (2019) Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline, BMJ 365 l2006
 
- 
    - Song Y, Zhao M, Zhang H, Zhang X, Zhao J, Xu J, Gao L (2016) Thyroid-Stimulating Hormone Levels Are Inversely Associated with Serum Total Bile Acid Levels: A Cross-Sectional Study. Endocr Pract 22(4):420–426 - DOI
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Medical
- Research Materials
- Miscellaneous
 
        